Loading…
CIK 0001017645 • 6 13F filings • May 14, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("general-atlantic-l-p","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | COM | $260.1M | 9.1%Prev: 12.7% | 13,167,733 SH | Decreased-11,119,494 SH |
| ALKAMI | COM | $276.6M | 9.6%Prev: 8.9% | 11,991,480 SH | Decreased |
| CENTESSA PHARMACEUTICALS | ADS | $153.0M | 5.3% | 6,117,715 SH | New |
| CHIME | COM SHS CL A | $535.1M | 18.6%Prev: 11.6% | 21,259,683 SH | Increased+2,050,923 SH |
| DLOCAL | CL A | $659.7M | 23.0% | 46,656,695 SH | New |
| EUROPEAN WAX CENTER | CL A | $47.2M | 1.6% | 13,110,492 SH | New |
| GROVE COLLABORATIVE | CL A | $2.7M | 0.1% | 2,474,859 SH | New |
| NURIX THERAPEUTICS | COM | $92.9M | 3.2% | 4,897,159 SH | New |
| PHARVARIS | COM | $222.9M | 7.8%Prev: 6.0% | 8,031,252 SH | Increased |
| REVOLUTION MEDICINES | COM | $224.0M | 7.8%Prev: 3.5% | 2,812,928 SH | Increased+338,500 SH |
| RISKIFIED | CL A | $26.5M | 0.9% | 5,324,998 SH | New |
| WEBULL | ORD SHS | $395K | 0.0%Prev: 3.2% | 50,816 SH | Decreased-7,148,051 SH |
| XP, INC | CL A | $371.6M | 12.9%Prev: 14.4% | 22,699,133 SH | Decreased-2,818,600 SH |
| 13F-HR |
| 0000950142-26-002338 |
| $2.91B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000950142-25-002176 | $3.63B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000950142-26-001406 | $2.15B | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0000950142-25-001365 | $2.98B | View |